U.S. markets open in 7 hours 16 minutes
  • S&P Futures

    3,861.75
    +13.50 (+0.35%)
     
  • Dow Futures

    31,120.00
    +107.00 (+0.35%)
     
  • Nasdaq Futures

    11,934.75
    +54.50 (+0.46%)
     
  • Russell 2000 Futures

    1,736.30
    +7.70 (+0.45%)
     
  • Crude Oil

    98.56
    +0.03 (+0.03%)
     
  • Gold

    1,744.00
    +7.50 (+0.43%)
     
  • Silver

    19.27
    +0.12 (+0.61%)
     
  • EUR/USD

    1.0213
    +0.0029 (+0.29%)
     
  • 10-Yr Bond

    2.9130
    0.0000 (0.00%)
     
  • Vix

    26.73
    -0.81 (-2.94%)
     
  • GBP/USD

    1.1940
    +0.0019 (+0.16%)
     
  • USD/JPY

    135.8270
    -0.0880 (-0.06%)
     
  • BTC-USD

    20,308.27
    +307.52 (+1.54%)
     
  • CMC Crypto 200

    441.64
    +6.11 (+1.40%)
     
  • FTSE 100

    7,107.77
    +82.30 (+1.17%)
     
  • Nikkei 225

    26,461.88
    +354.23 (+1.36%)
     

Celldex to Present at the 2021 Cantor Virtual Global Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

HAMPTON, N.J., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that senior management will participate in a fireside chat at the 2021 Cantor Virtual Global Healthcare Conference on Wednesday, September 29, 2021 at 1:20 p.m. ET.

A webcast of the presentation will be available on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay will be available for 30 days following the event.

About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Visit www.celldex.com.

Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com

Patrick Till
Senior Director, Investor Relations & Corporate Communications
(484) 788-8560
ptill@celldex.com